Evidence map›Paper›PMID 35096337›Full record

ArticleArchives of Razi Institute2021

Effect of Lipopolysaccharide from

M Aal-Aaboda, A R Abu Raghif, N R Hadi

Open access · greenAbstract read
In one paragraph

Article in Archives of Razi Institute, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

M Aal-AabodaDepartment of Pharmacology, Faculty of Pharmacy, University of Misan, Amarah, Iraq.
A R Abu RaghifDepartment of Pharmacology, Faculty of Medicine, Al-Nahrain University, Baghdad, Iraq.
N R HadiDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
Nahrain University · IQUniversity of Kufa · IQUniversity of Misan · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia/reperfusion injury (IRI) is caused by a sudden temporary impairment of the blood flow to the particular organ. The IRI of the kidneys is one of the main causes of acute kidney injury. A vigorous inflammatory and oxidative stress response to hypoxia and reperfusion usually happens as IRI consequences that disturb the organ function. The current study aimed to investigate the effect of antagonizing toll-like receptors (TLRs) effects by lipopolysaccharide obtained from

Indexed as

Reperfusion InjuryRhodobacter sphaeroidesAnimalsIschemiaKidneyLipopolysaccharidesMaleOxidative StressRatsRats, WistarLipopolysaccharidesF2-IsoprostaneIL-1βIL-6Lps-RsNeutrophil Gelatinase Associated LipocalinNgalRenal Ischemic Reperfusion InjuryTLR2TLR4TNF-α

Identifiers

PMID35096337
PMCPMC8791000
OpenAlexW3203441209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.